Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.47
-0.11 (-0.45%)
At close: Jul 18, 2025, 4:00 PM
24.48
+0.01 (0.04%)
After-hours: Jul 18, 2025, 7:04 PM EDT
Pfizer Revenue
Pfizer had revenue of $13.72B in the quarter ending March 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 11.65% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+11.65%
P/S Ratio
2.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
139.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
PFE News
- 4 hours ago - July's 5 Dividend Growth Stocks With Yields Up To 7.96% - Seeking Alpha
- 1 day ago - Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount - CNBC
- 1 day ago - Dividend Harvesting Portfolio Week 228: $22,800 Allocated, $2,399.27 In Projected Dividends - Seeking Alpha
- 1 day ago - Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients - Reuters
- 1 day ago - Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price - WSJ
- 7 days ago - Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys - Seeking Alpha
- 8 days ago - 3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies - Seeking Alpha
- 8 days ago - Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win - Reuters